<?xml version="1.0" encoding="UTF-8"?>
<fig id="pone.0230406.g007" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0230406.g007</object-id>
 <label>Fig 7</label>
 <caption>
  <title>Impact of reactive mass vaccination on cumulative incidence and mortality associated with Ebola virus disease, compared with H30-G5 prophylactic vaccination strategy.</title>
  <p>Vaccine profile assumed for mass vaccination: Time to onset of protection: 7 days, duration of protection: 180 days, efficacy: 100%. Daily rate at which vaccination is carried out: 0.1% (general population) and 5% (HCW). Abbreviations: HCW, health care worker; H30-G5, vaccination of 30% of all HCW plus 5% of the general population.</p>
 </caption>
 <graphic xlink:href="pone.0230406.g007" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
